Cannabis Sales Slowed Ahead of the Summer

The weakening growth trends in May that we discussed last month continued in June, according to cannabis data analytics firm BDSA. The comparisons to a year ago, when demand surged during the pandemic, have created challenges, with two states, Colorado and Oregon, seeing sales decline compared to then. Most of the markets saw a sequential decline, with some in excess of the 3.2% due to one less day in the month than in May. In this review, we will look at the markets one-by-one, beginning with the more mature Western markets and then concluding with the newer Eastern markets.

Western Markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In April, growth ranged from -3%% in Colorado to 29% in Arizona compared to a year ago.


Arizona transitioned to adult-use in late January, but this is the third month that BDSA included adult-use sales. Total cannabis sales grew 29% to $117.9 million, with adult-use representing $53.7 million, down slightly from May. Medical cannabis sales fell 30% to $64 million. Sequentially, overall growth fell 7.1%, with medical falling 4% and adult-use decreasing 0.4%. Growth was strong across all categories, but the highest growth by far was in pre-rolls, which gained 184%.


Annual sales grew 13.8% to $331.8 million, down 5% from June and 7% from the record level in April. Flower expanded 8%, with low double-digit growth for ingestibles and concentrates, while pre-rolls expanded by more than 50%.


The mature market of Colorado, which has shown vigorous growth over the past year, declined 5% compared to a year ago. Last June, sales had grown 30.4%, so compared to two year ago, sales expanded 23.9% (11.3% compound growth). Sequentially, sales dropped 5.3% to $190.5 million. Flower declined 18%, while pre-rolls grew 26%. Ingestibles grew 7%, while concentrates expanded by 8%.


Given that Las Vegas fully reopened during June, the 8.8 sequential decline was disappointing. Compared to a year ago, sales expanded by 19.5% in June to $79.7 million. Edibles expanded 11%, with concentrates growing 15%, flower by 21% and pre-rolls by 27%.


Oregon, another mature market that had explosive growth following the pandemic, declined year-over-year by 1%, with sales of $99.3 million falling 6% from May. Flower declined 5%, while pre-rolls grew 30%. Edibles fell by 28%, while concentrates grew 11%.

Eastern Markets

In the newer markets, the annual rate of growth continued to slow in all markets. Note that we wrote about June data for Illinois based on the state’s data a month ago. BDSA provides more comprehensive data than the state, breaking sales down by product types. The state reported very strong July adult-use sales, with growth of 110% to a record $127.8 million. Medical sales should be reported this coming week. Note that BDSA has begun providing data for Florida, Michigan and Pennsylvania as of January. Florida sales increased 3% sequentially to a record $155.7 million, while Pennsylvania’s fell for the second month in a row to $102.7 million. Michigan, which we previously detailed, saw overall sales flat at $149 million, up 65% from a year ago. BDSA includes accessories, which helped boost the sales in June to $151.7 million from $150.9 million in May.


Illinois combined adult-use and medical sales fell by 2% in June, including accessories, to $147.3 million, which was up 90.6% from a year ago. Flower led all categories, increasing 111%, with pre-rolls at 104%. Concentrates expanded 76%, while ingestibles grew 68%.


This medical market continued to see slower growth, with year-over-year growth at just 19%. Sales fell sequentially by 4% to $45 million. Edibles led all categories, increasing 33%.


The growing store base helped Massachusetts to post solid numbers, with sales expanding 0.6% from May and 79% from a  year ago to $132.9 million. Flower expanded by 60%, while concentrates grew 74%. Ingestibles expanded 87%, and pre-rolls soared by 164%. This category represented 14.6% of overall sales.

For readers interested in a deeper look at cannabis markets across these eight states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with unlimited access to the most accurate and actionable data and analysis.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter